Baseline Characteristics | Patients With Elevated HbA1c | Patients With Normal HbA1c |
---|---|---|
Age (y), studies = 12, n = 10734 | 64 | 65 |
Male (%), studies = 12, n = 10734 | 64 | 72 |
History of Hypertension (%), studies = 10, n = 10242 | 74 | 59 |
History of Heart failure (%), studies = 4, n = 5276 | 22 | 14 |
Previous MI (%), studies = 3, n = 4219 | 48 | 24 |
Hyperlipidemia (%), studies = 3, n = 4149 | 36 | 35 |
Smoker (%), studies = 7, n = 3770 | 40 | 41 |
Body mass index (kg/m2), studies = 6, n = 2990 | 27 | 29 |
Renal insufficiency (%), studies = 5, n = 5806 | 10 | 7 |
β-Blocker (%), studies = 4, n = 3794 | 77 | 77 |
Angiotensin-converting enzyme (ACE) inhibitors (%), studies = 3, n = 1448 | 53 | 39 |
Lipid lowering drugs (%), studies = 4, n = 3794 | 67 | 41 |